Table 1.
Individual pathological, clinical, MRI, and MET-PET data from the 52 patients with definite pathology
| Clinical Data |
MRI Data |
MET-PET Data |
Pathology | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient No. | Gender | Age, y | Epilepsy Onset, y | Epilepsy Duration, y | Location | Side | Tumor Size (biggest diameter, mm) | Gd | Uptake on Visual Analysis | TCr | TOr | |
| 1 | F | 21 | 3 | 18 | mT + O | L | 55 | − | Normal | 0.89 | 0.60 | DNT |
| 3 | M | 64 | 54 | 10 | mT | R | 18 | − | Normal | 1.11 | 0.84 | DNT |
| 6 | F | 39 | 38 | 1 | lT | R | 20 | − | Moderate | 1.25 | 0.92 | DNT |
| 7 | F | 42 | 37 | 5 | mT | R | 19 | − | Normal | 0.55 | 0.38 | DNT |
| 9 | F | 17 | 6 | 11 | Fr | L | 30 | − | Normal | 0.92 | 0.67 | DNT |
| 11 | M | 5 | 4 | 1 | Fr | L | 16 | − | Normal | 0.93 | 0.74 | DNT |
| 12 | F | 27 | 25 | 1.5 | lT | L | 27 | NA | Moderate | 1.81 | 1.11 | DNT |
| 17 | M | 37 | 34 | 3 | mT | L | 10 | + | Moderate | 1.44 | 0.81 | DNT |
| 21 | M | 15 | 14 | 1 | Fr + I | L | 37 | − | Normal | 0.90 | 0.88 | DNT |
| 22 | F | 48 | 39 | 9 | mT | L | 20 | − | Moderate | 1.63 | 1.02 | DNT |
| 24 | M | 12 | 9 | 3 | lT | L | 39 | − | Normal | 0.91 | 0.57 | DNT |
| 26 | F | 46 | 38 | 8 | Fr + P | R | 48 | − | Moderate | 1.35 | 0.93 | DNT |
| 28 | F | 18 | 8 | 10 | mT + lT | L | 29 | − | Moderate | 1.46 | 0.95 | DNT |
| 32 | F | 12 | 11 | 1 | lT | R | 15 | − | Moderate | 1.70 | 1.09 | DNT |
| 40 | M | 32 | 18 | 14 | mT | L | 25 | − | Normal | 0.71 | 0.52 | DNT |
| 43 | F | 10 | 7 | 3 | lT + O | L | 36 | − | Moderate | 1.49 | 1.00 | DNT |
| 47 | M | 27 | 18 | 9 | mT | L | 23 | − | Moderate | 1.44 | 0.88 | DNT |
| 49 | F | 18 | 17 | 1 | mT | L | 17 | − | Moderate | 1.44 | 0.94 | DNT |
| 50 | F | 62 | 55 | 7 | mT | R | 20 | − | Normal | 1.38 | 0.82 | DNT |
| 23 | M | 51 | 21 | 30 | mT | R | 30 | + | Marked | 2.29 | 1.44 | DNT + pilocytic component |
| 39 | F | 39 | 35 | 4 | mT | R | 21 | − | Marked | 1.86 | 1.21 | DNT + pilocytic component |
| 2 | F | 35 | 18 | 17 | lT + I + Fr | L | 56 | + | Marked | 2.21 | 1.63 | Ganglioglioma |
| 4 | M | 6 | 5 | 1 | mT | L | 15 | NA | Marked | 2.46 | 1.53 | Ganglioglioma |
| 5 | M | 12 | 10 | 2 | mT | R | 22 | + | Moderate | 1.93 | 1.11 | Ganglioglioma |
| 19 | M | 19 | 11 | 8 | lT | R | 10 | + | Marked | 2.06 | 1.61 | Ganglioglioma |
| 29 | F | 33 | 30 | 3 | mT | R | 15 | − | Moderate | 1.42 | 0.93 | Ganglioglioma |
| 30 | F | 13 | 8 | 5 | lT | L | 14 | − | Marked | 2.90 | 2.03 | Ganglioglioma |
| 33 | M | 15 | 9 | 6 | lT | R | 16 | + | Marked | 1.78 | 1.45 | Ganglioglioma |
| 37 | M | 45 | 20 | 25 | lT | L | 15 | NA | Marked | 2.07 | 1.43 | Ganglioglioma |
| 45 | F | 43 | 4 | 39 | lT + P | R | 28 | + | Moderate | 1.59 | 1.13 | Ganglioglioma |
| 46 | F | 16 | 2 | 14 | mT | L | 21 | + | Moderate | 2.16 | 1.29 | Ganglioglioma |
| 8 | F | 37 | 34 | 3 | mT + O | L | 90 | − | Marked | 2.58 | 2.14 | Oligoastrocytoma II |
| 10 | M | 20 | 19 | 1 | Fr | L | 53 | − | Marked | 1.76 | 1.29 | Oligodendroglioma II |
| 13 | M | 28 | 27 | 1 | Fr | R | 30 | − | Moderate | 1.53 | 1.09 | Oligoastrocytoma II |
| 14 | F | 64 | 63.5 | 0.5 | Fr | R | 28 | − | Marked | 2.17 | 1.51 | Oligodendroglioma II |
| 16 | M | 38 | 37.5 | 0.5 | Fr | R | 36 | − | Moderate | 1.46 | 1.14 | Oligodendroglioma II |
| 18 | M | 41 | 35 | 6 | P + lT | L | 52 | − | Marked | 2.89 | 2.04 | Oligodendroglioma II |
| 20 | M | 42 | 33 | 9 | Fr | R | 26 | − | Moderate | 1.50 | 1.15 | Oligoastrocytoma II |
| 27 | F | 39 | 38 | 1 | lT + I | R | 60 | − | Marked | 5.35 | 3.41 | Astrocytoma II |
| 31 | M | 40 | 37 | 3 | lT | L | 69 | − | Marked | 2.44 | 1.71 | Astrocytoma II |
| 34 | F | 24 | 16 | 8 | I | R | 54 | − | Moderate | 1.31 | 1.07 | Oligoastrocytoma II |
| 35 | M | 26 | 25 | 0.66 | Fr + I | R | 69 | − | Marked | 2.34 | 1.32 | Oligoastrocytoma II |
| 36 | F | 53 | 46 | 7 | lT + I | L | 45 | + | Moderate | 1.28 | 0.93 | Oligodendroglioma II |
| 38 | M | 40 | 25 | 15 | Fr | L | 33 | − | Marked | 2.42 | 1.69 | Oligodendroglioma II |
| 41 | M | 37 | 36 | 1 | Fr | R | 35 | − | Marked | 2.94 | 1.74 | Oligodendroglioma II |
| 42 | M | 28 | 27 | 1 | Fr | R | 20 | + | Moderate | 1.33 | 1.05 | Oligodendroglioma II |
| 44 | M | 38 | 37 | 1 | Fr + P | L | 60 | NA | Moderate | 1.24 | 1.23 | Oligodendroglioma II |
| 48 | F | 7 | 0 | 7 | lT + I + Fr | L | 62 | − | Moderate | 1.46 | 0.87 | Oligodendroglioma II |
| 51 | M | 49 | 47 | 2 | Fr | L | 60 | + | Moderate | 1.48 | 1.10 | Oligodendroglioma II |
| 52 | M | 48 | 49 | 0.3 | Fr | L | 54 | − | Marked | 1.63 | 1.09 | Oligodendroglioma II |
| 15 | F | 50 | 44 | 6 | P + O | L | 43 | − | Marked | 2.58 | 1.67 | Oligodendroglioma III |
| 25 | M | 49 | 18 | 31 | Fr | L | 40 | + | Marked | 2.65 | 2.11 | Oligodendroglioma III |
Abbreviations: Gd, gadolinium; DNT, dysembryoplastic neuroepithelial tumors.